{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"27"}],"units":"Participants"}],"description":"Venous thromboembolism is the formation of a blood clot (thrombus) inside a blood vessel, obstructing the flow of blood through the circulatory system.","groups":[{"description":"This number includes all patients that completed 4 weeks of the study and were treated with 2.5 mg of Fondaparinux on days 1-28.","id":"OG000","title":"Fondaparinux Patients Who Completed Study"}],"paramType":"NUMBER","populationDescription":"The number includes those patients who completed the study and are evaluable for this outcome measure.","reportingStatus":"POSTED","timeFrame":"Week 4 (Days 28-35)","title":"Number of Patients With Venous Thromboembolism at Week 4","type":"PRIMARY","unitOfMeasure":"Participants"}